Size of Hepatocellular Carcinoma as a Predictor of Radiologic Response to Transarterial Chemoembolization
/ 0
- Details
- Category: Vol. 82, December 2014
- Hits: 591
Size of Hepatocellular Carcinoma as a Predictor of Radiologic Response to Transarterial Chemoembolization, MOHAMMAD A. AL-SHATOURI, AHMAD T. AHMAD, TALAL A. AMER, TAREK H. KHALIL and MOHAMMAD R. HABBA
Abstract
Background: Hepatocellular carcinoma (HCC) is common in Egypt and is expected to rise. Transarterial chemoembo-lization (TACE) is the most common treatment modality as a standard of care for intermediate stage HCC. Lesion size is a decisive factor in management of HCC. Large size is hy-pothesized to be a prognostic factor against complete radiologic response.
Objective: To assess the value of lesion size in predicting radiologic response to TACE.
Material and Methods: Forty seven HCCs were assessed for its distribution of lipiodol after TACE. Multiphase computed tomography (CT) was done 1 month after TACE to assess Radiologic response. HCC was classified according to the size <5cm, 5-10cm and >10cm in diameter.
Results: Lesions size ranged from 6mm to 15cm with a median of 7.3cm. Twenty five lesions (53.2%) were <5cm in diameter. Nine lesions (19.2%) were >cm in diameter. Using modified RECIST, complete response was noted in 13 lesions (27.7%), partial response in 25 lesions (53.2%) and stable disease in 9 lesions (19.1%) one month after TACE. Lipiodol covered >!75% of the lesion in 30 lesions (63%) and <75% in 13 lesions (27.7%) and 0% in 4 lesions (8.5%). Eight out of 9 lesions >10cm in diameter (88%) and 17 out of 25 lesions <5cm in diameter (68%) showed Lipiodol defects one month after TACE. A diameter >1 0cm was significantly correlated with incomplete Radiologic response (p-value 0.0002). A diameter of <5cm was not significantly correlated with Ra-diologic response. Lesion size >10cm was predictive of incomplete response showing a positive predictive value (PPV), prevalence weighted likelihood ratio (pwLR+), post test probability and odds ratio of 88.7% (95% Confidence interval (CI) 50.7-99.4%), 7.85 (95% CI 1.24-51.5), 95.4% (compared with pretest probability of 72.3%) and 20.7: 1 (compared with pretest odds ratio of 2.6: 1) respectively. Lesion size <5cm did not predict complete radiologic response as the PPV, pwLR+, post test probability and odds ratio were 32.2% (95% CI 15.7-53.6), 0.47% (95% CI 0.25-0.89), 15.4% (compared with a pretest probability of 27.6%) and 0.18: 1 (compared with pretest odds ratio of 0.38) respectively.
Conclusion: HCC >10cm in diameter are very likely to show lipiodol defects after TACE. Lesions <5cm are not in advantage towards complete response.